Purity: | 75% |
---|---|
Brand Name: | Seven star |
Grade Standard: | Medicine Grade |
Type: | Antibiotic and Antimicrobial Agents,Antiparasitic Agents |
CAS No.: | H20083665 |
Quick Details
Specifications
Drug description
Dosage (1) initial dose of prophylactic treatment for migraine: for 65 years of age
the following patients can be given 2 tablets per night at the beginning of treatment and 1 pill per night for patients over 65 years of age. If depression, extrapyramidal reaction and other unacceptable adverse reactions occur in the treatment, the drug should be stopped in time. If there is no significant improvement after 2 months of treatment, the patient can be regarded as not responding to this product and can stop using the drug. Maintenance treatment: if the curative effect is satisfactory, when the patient needs to maintain the treatment, it should be reduced to 5 days a week (the same dose) and 2 days after withdrawal. Even if preventive maintenance therapy is effective and well tolerant, it should be stopped after 6 months of treatment and should be readministered only when it recur. (2). The daily dose of vertigo is related to the daily dose of vertigo. The same, but should be stopped in time after the symptoms should be controlled, the first course of treatment is usually less than 2 months. If chronic vertigo is treated for 1 month or sudden vertigo for 2 months. after the symptoms are not, see any improvement, should be regarded as the patient did not respond to this product, should stop the drug.
Taboo if you have a history of allergy to this drug, or if you have a history of depression, ban it
this medicine, acute cerebral hemorrhagic disease should not be used.
Dosage (1) initial dose of prophylactic treatment for migraine: for 65 years of age
the following patients can be given 2 tablets per night at the beginning of treatment and 1 pill per night for patients over 65 years of age. If depression, extrapyramidal reaction and other unacceptable adverse reactions occur in the treatment, the drug should be stopped in time. If there is no significant improvement after 2 months of treatment, the patient can be regarded as not responding to this product and can stop using the drug. Maintenance treatment: if the curative effect is satisfactory, when the patient needs to maintain the treatment, it should be reduced to 5 days a week (the same dose) and 2 days after withdrawal. Even if preventive maintenance therapy is effective and well tolerant, it should be stopped after 6 months of treatment and should be readministered only when it recur. (2). The daily dose of vertigo is related to the daily dose of vertigo. The same, but should be stopped in time after the symptoms should be controlled, the first course of treatment is usually less than 2 months. If chronic vertigo is treated for 1 month or sudden vertigo for 2 months. after the symptoms are not, see any improvement, should be regarded as the patient did not respond to this product, should stop the drug.
Taboo if you have a history of allergy to this drug, or if you have a history of depression, ban it
this medicine, acute cerebral hemorrhagic disease should not be used.